ATE255892T1 - Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa - Google Patents

Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa

Info

Publication number
ATE255892T1
ATE255892T1 AT00905841T AT00905841T ATE255892T1 AT E255892 T1 ATE255892 T1 AT E255892T1 AT 00905841 T AT00905841 T AT 00905841T AT 00905841 T AT00905841 T AT 00905841T AT E255892 T1 ATE255892 T1 AT E255892T1
Authority
AT
Austria
Prior art keywords
bulimia nervosa
anticonvulsive
derivatives
treat bulimia
treat
Prior art date
Application number
AT00905841T
Other languages
English (en)
Inventor
Scott P Hoopes
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE255892T1 publication Critical patent/ATE255892T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT00905841T 1999-02-01 2000-01-31 Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa ATE255892T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11805799P 1999-02-01 1999-02-01
PCT/US2000/002334 WO2000044374A1 (en) 1999-02-01 2000-01-31 Use of anticonvulsant derivatives for treating bulimia nervosa

Publications (1)

Publication Number Publication Date
ATE255892T1 true ATE255892T1 (de) 2003-12-15

Family

ID=22376270

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00905841T ATE255892T1 (de) 1999-02-01 2000-01-31 Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa

Country Status (23)

Country Link
EP (1) EP1148874B1 (de)
JP (1) JP2002535363A (de)
KR (1) KR100664618B1 (de)
CN (1) CN1196482C (de)
AR (1) AR029331A1 (de)
AT (1) ATE255892T1 (de)
AU (1) AU764703B2 (de)
BR (1) BR0007897A (de)
CA (1) CA2360677C (de)
CZ (1) CZ295594B6 (de)
DE (1) DE60007078T2 (de)
DK (1) DK1148874T3 (de)
ES (1) ES2211507T3 (de)
HU (1) HUP0105420A3 (de)
IL (1) IL144407A0 (de)
MX (1) MXPA01007758A (de)
NO (1) NO20013725D0 (de)
NZ (1) NZ513114A (de)
PT (1) PT1148874E (de)
TR (1) TR200102205T2 (de)
TW (1) TW565446B (de)
WO (1) WO2000044374A1 (de)
ZA (1) ZA200107212B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
NZ513643A (en) 1999-02-24 2005-04-29 Univ Cincinnati Use of sulfamate derivatives for treating impulse control disorders
AU2002227052A1 (en) 2000-11-30 2002-06-11 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
US6462084B1 (en) 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
IT1248588B (it) * 1991-06-28 1995-01-19 Gaetano Crepaldi Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari.

Also Published As

Publication number Publication date
EP1148874B1 (de) 2003-12-10
HUP0105420A3 (en) 2003-03-28
TW565446B (en) 2003-12-11
NO20013725L (no) 2001-07-30
WO2000044374A1 (en) 2000-08-03
CZ295594B6 (cs) 2005-08-17
IL144407A0 (en) 2002-05-23
KR20010101665A (ko) 2001-11-14
AU2746200A (en) 2000-08-18
DE60007078T2 (de) 2004-12-16
MXPA01007758A (es) 2003-06-24
CA2360677C (en) 2005-07-05
JP2002535363A (ja) 2002-10-22
BR0007897A (pt) 2001-10-30
DE60007078D1 (de) 2004-01-22
TR200102205T2 (tr) 2002-01-21
PT1148874E (pt) 2004-04-30
EP1148874A1 (de) 2001-10-31
ES2211507T3 (es) 2004-07-16
CA2360677A1 (en) 2000-08-03
AU764703B2 (en) 2003-08-28
ZA200107212B (en) 2002-12-02
CN1338931A (zh) 2002-03-06
HUP0105420A2 (hu) 2002-05-29
KR100664618B1 (ko) 2007-01-04
DK1148874T3 (da) 2004-03-29
NZ513114A (en) 2003-10-31
AR029331A1 (es) 2003-06-25
NO20013725D0 (no) 2001-07-30
CN1196482C (zh) 2005-04-13

Similar Documents

Publication Publication Date Title
ATE365042T1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
ATE288748T1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE308364T1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
ATE353218T1 (de) Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis
ATE338552T1 (de) Verwendungen von et743 zur behandlung von krebs
DE60015516D1 (de) Verwendung von makroliden zur behandlung von trockenen augen
ATE339955T1 (de) Verwendung von escitalopram zur behandlung von generalisierten angstzuständen
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
EP1117431A4 (de) Behandlung von acidose
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
ATE410181T1 (de) Verwendung von intereferon gamma zur behandlung von herzhypertrophie
ATE289196T1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE326969T1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
ATE270102T1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
ATE209891T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis
ATE317261T1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
DE60120990D1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE60103503D1 (de) Verwendung von fsh zur behandlung von infertilität
ATE433323T1 (de) Verwendung von erythropoietin zur behandlung von primärer hämochromatosen
DE60007078D1 (de) Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa
ATE270545T1 (de) Verwendung von nmda antagonisten zur behandlung des reizkolons
ATE404203T1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1148874

Country of ref document: EP

REN Ceased due to non-payment of the annual fee